Related Experiment Video
Updated: Jun 9, 2025

07:07
Errors as a Means of Reducing Impulsive Food Choice
Published on: June 5, 2016
8.6K
Restructuring the FDA's Food Program: Promises and Pitfalls
Sammer Marzouk1, Kranti C Rumalla1, Peter G Lurie2
1Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA.
Foods (Basel, Switzerland)
|October 26, 2024
Summary
The US Food and Drug Administration reorganized its food program after a Cronobacter sakazakii infant formula outbreak. These changes aim to improve the Human Foods Program and public health impact.
Area of Science:
- Food Safety
- Public Health Policy
- Regulatory Science
Background:
- An outbreak of Cronobacter sakazakii infection linked to infant formula prompted regulatory review.
- The US Food and Drug Administration (FDA) initiated a comprehensive assessment of its food safety protocols.
- Previous structures necessitated significant reform to address emerging public health threats effectively.
Purpose of the Study:
- To detail the organizational changes implemented within the FDA's food program.
- To analyze the anticipated benefits of the new Human Foods Program.
- To identify further necessary actions for enhancing the FDA's public health influence.
Main Methods:
- Review of commissioned reports and internal assessments.
- Analysis of the FDA's food program reorganization strategy.
- Evaluation of the potential impact of the new program on public health outcomes.
Main Results:
- Implementation of a major reorganization of the FDA's food program, effective October 1, 2024.
- Anticipated improvements in the oversight and safety functions of the new Human Foods Program.
- Identification of key areas requiring further development to bolster the agency's public health mission.
Conclusions:
- The FDA's food program restructuring is a significant step towards enhanced food safety.
- Continued efforts are crucial to maximize the effectiveness of the new Human Foods Program.
- Proactive measures and strategic enhancements are vital for the agency's sustained impact on public health.
Related Concept Videos
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Prescription, Nonprescription and Orphan Drugs
699
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
699
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K

